Genome’s dark matter offers clues to major challenge in prostate cancer
Researchers identify a lncRNA that provides insight into a key driver of prostate cancer — and a potential target for future therapy
Researchers identified a novel gene they named ARLNC1 that controls signals from the androgen receptor, a key player in prostate cancer. Knocking down this long non-coding RNA in mice led to cancer cell death, suggesting this may be a key target for future therapies. The study is published in Nature Genetics.